Additionally, tafamidis does not effectively inhibit seeded TTR aggregation, where extracted amyloidogenic fibrils from patients with TTR amyloidosis are used as seeds for aggregation assays in vitro (5). This evidence concerns the gene TTR and amyloidosis.